CQ52. What Are Useful Imaging Studies to Detect Lesions of Recurrence for Medullary Carcinoma with Elevation of Postoperative Calcitonin Level?

  • Minoru Fujimori
  • Hisato Hara
  • Hidemitsu Tsutsui


Serum calcitonin level is an excellent tumor marker of medullary thyroid carcinoma and postoperative elevation of calcitonin suggests carcinoma recurrence. For such cases, useful imaging studies to detect the lesions of recurrence are important.


Thyroid Carcinoma Bone Scintigraphy Mediastinal Lymph Node Medullary Thyroid Carcinoma Medullary Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Diehl M, Risse JH, Brandt-Mainz K et al (2001) Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 28: 1671–1676 (RS)PubMedCrossRefGoogle Scholar
  2. 2.
    Machens A, Schneyer U, Holzhausen HJ et al (2005) Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029–2034 (RS)PubMedCrossRefGoogle Scholar
  3. 3.
    Giraudet AL, Vanel D, Leboulleux S et al (2007) Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 92:4185–4190 (PS)PubMedCrossRefGoogle Scholar
  4. 4.
    Mirallie E, Vuillez JP, Bardet S et al (2005) High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer. J Clin Endocrinol Metab 90:779–788 (RS)PubMedCrossRefGoogle Scholar
  5. 5.
    Gotthardt M, Battmann A, Hoffken H et al (2004) 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Commun 25:439–443 (RS)PubMedCrossRefGoogle Scholar
  6. 6.
    Iagaru A, Masamed R, Singer PA et al (2007) Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CT. J Clin Endocrinol Commun 9:72–77 (RS)Google Scholar
  7. 7.
    Rubello D, Rampin L, Nanni C et al (2008) The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study. Eur J Surg Oncol 34:581–586 (PS)PubMedCrossRefGoogle Scholar
  8. 8.
    Szakall S Jr, Esik O, Bajzik G et al (2002) 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 43:66–71 (PS)PubMedGoogle Scholar
  9. 9.
    Ugur O, Kostakoglu L, Guler N et al (1996) Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 23:1367–1371 (RS)PubMedCrossRefGoogle Scholar
  10. 10.
    Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612 (Others)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Minoru Fujimori
    • 1
  • Hisato Hara
    • 2
  • Hidemitsu Tsutsui
    • 3
  1. 1.Department of Breast SurgeryTokyo Medical University, Ibaraki Medical CenterAmimachi, InashikigunJapan
  2. 2.Department of Breast and Endocrine Surgery, Clinical Science, Graduate School of Comprehensive Human SciencesUniversity of TsukubaTsukubaJapan
  3. 3.Department of Thoracic and Thyroid SurgeryTokyo Medical UniversityTokyoJapan

Personalised recommendations